Conservative management of suspected bladder rupture after augmentation enterocystoplasty.
Bladder rupture after augmentation enterocystoplasty is a potentially life-threatening condition. We reviewed our experience with 13 patients who presented to our institution with 15 episodes of sudden onset of abdominal pain and rebound tenderness, and were diagnosed on clinical grounds to have peritonitis secondary to a suspected bladder augmentation rupture. (Three patients had had similar episodes treated previously elsewhere with abdominal exploration and repair of an augmentation rupture.) These episodes were initially managed with hospitalization, bladder drainage with an indwelling catheter, intravenous antibiotics and serial abdominal examinations. Cystogram and/or computerized tomography was diagnostic in only 3 of 7 cases in which it was performed. In 13 of 15 instances signs and symptoms of peritonitis quickly resolved, and intermittent catheterization was resumed after a mean of 12 days. In the remaining 2 patients delayed surgical repair of a bladder rupture was done in 1, and exploration and repair of an incarcerated internal hernia were done in 1. Although prompt abdominal exploration is the gold standard for suspected bladder augmentation rupture, treatment of peritonitis as bladder rupture in patients with a bladder augmentation by nonoperative techniques was successful in 87% of episodes.
Department of Urology, Medical College of Ohio, Toledo 43699.
J W
JW
Slaton
K A
KA
Kropp
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004322:Drainage; D005260:Female; D006801:Humans; D008297:Male; D010538:Peritonitis / Q000209:etiology / Q000628:therapy; D011379:Prognosis; D012422:Rupture, Spontaneous; D014057:Tomography, X-Ray Computed; D001743:Urinary Bladder / Q000601:surgery*; D001745:Urinary Bladder Diseases / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D014546:Urinary Catheterization; D014547:Urinary Diversion / Q000009:adverse effects*
D000900:Anti-Bacterial Agents